Dr. Reddy's Laboratories Limited RDY

RDY Company Overview

Dr. Reddy’s Laboratories Limited is an India-based multinational pharmaceutical company engaged in the development, manufacturing, and commercialization of generic medicines, branded pharmaceuticals, biosimilars, active pharmaceutical ingredients (APIs), and over-the-counter healthcare products. The company operates primarily within the global pharmaceutical and biotechnology industries, with business activities spanning research, formulation development, manufacturing, licensing, and commercialization. Its core revenue drivers include generic formulations sold in regulated markets such as the United States and Europe, branded generics in emerging markets, pharmaceutical services and APIs, and biosimilar products.

Founded in 1984 by Dr. Kallam Anji Reddy, the company began as an API manufacturer and gradually expanded into vertically integrated pharmaceutical operations. Over time, Dr. Reddy’s evolved into one of India’s largest pharmaceutical exporters, with a significant presence in the U.S. generics market and growing capabilities in complex generics, injectables, biosimilars, and digital therapeutics. The company’s strategic positioning is supported by integrated manufacturing capabilities, global regulatory experience, cost-efficient production infrastructure, and a diversified geographic revenue base across developed and emerging markets.